ArticleJournal of virus eradication2018
The contribution of observational studies in supporting the WHO 'treat all' recommendation for HIV/AIDS.
Article in Journal of virus eradication, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Documenting HIV service delivery and adoption of evidence-based practices in HIV care programs: A protocol for a cross-sectional survey of HIV clinics participating in the International epidemiology Databases to Evaluate AIDS (IeDEA).medRxiv : the preprint server for health sciences · 2026Article
- Progress Toward the Health-Related Sustainable Development Goals: A Case Study of the Academic Model Providing Access to Healthcare (AMPATH).Journal of general internal medicine · 2026Article
- Pharmacoeconomic perspectives on HIV: integrating data for long-term treatment and prevention.Frontiers in medicine · 2025Review
- "Going into the black box": a policy analysis of how the World Health Organization uses evidence to inform guideline recommendations.Frontiers in public health · 2024Article
- Regression discontinuity analysis demonstrated varied effect of Treat-All on CD4 testing among Southern African countries.Journal of clinical epidemiology · 2021Article
- Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimens.International journal of STD & AIDS · 2021Article
- Antiretroviral Therapy Use and HIV Transmission Among Discordant Couples in Nonresearch Settings in Kigali, Rwanda.Sexually transmitted diseases · 2021Article
- Predictors of retention in the prospective HIV prevention OKAPI cohort in Kinshasa.Scientific reports · 2021Observational
- Global emerging resistance in pediatric infections with TB, HIV, and gram-negative pathogens.Paediatrics and international child health · 2021Review
- Implications of COVID-19 for HIV Research: data sources, indicators and longitudinal analyses.Journal of the International AIDS Society · 2020Article
- Impact of Universal Antiretroviral Treatment Eligibility on Rapid Treatment Initiation Among Young Adolescents with Human Immunodeficiency Virus in Sub-Saharan Africa.The Journal of infectious diseases · 2020Article
- Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention After Expanded ART Eligibility in a National Cohort From 2011 to 2017.Journal of acquired immune deficiency syndromes (1999) · 2020Article
- HIV treatment outcomes among people with initiation CD4 counts >500 cells/µL after implementation of Treat All in South African public clinics: a retrospective cohort study.Journal of the International AIDS Society · 2020Article
- The Changing Science of HIV Epidemiology in the United States.American journal of epidemiology · 2019Review
- IeDEA-WHO Research-Policy Collaboration: contributing real-world evidence to HIV progress reporting and guideline development.Journal of virus eradication · 2018Article
- Treating all people living with HIV in sub-Saharan Africa: a new era calling for new approaches.Journal of virus eradication · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In 2015, the World Health Organization (WHO) recommended that all people living with HIV (PLWH) should start antiretroviral therapy (ART) irrespective of clinical or immune status. This recommendation followed almost 20 years of research into the clinical and population-level benefits and risks of starting ART early compared with deferring treatment. This article summarises the ways in which observational data support the work of WHO, including the support provided by the International epidemiology Databases to Evaluate AIDS (IeDEA), taking the example of 'treat all'.
Identifiers
30515308PMC6248853What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.